台灣病理學會

Taiwan Society of PathologyThe Taiwan Division of the International Academy of Pathology

國內學術活動 / 學術活動 / 國內學術活動

112.12.2~3 -2023 亞澳肺臟病理學會年會

[國內] 台中榮民總醫院第一會議室
主講人 詳細見節目表
主辦單位 亞澳肺臟病理學會、台灣病理學會
負責人 黃秀芬
協辦單位 財團法人國家衛生研究院 、醫療財團法人病理發展基金會台北病理中心、台灣胸腔及心臟血管外科學會、台灣胸腔暨重症加護醫學會、中華民國重症醫學會、台灣分級醫療健康長照促進學會、台中榮民總醫院病理檢驗部
活動內容

The 7th Asia-Australasia Pulmonary Pathology Society Annual Conference 

Lung Pathology in the Era of Precision Medicine

Date: December 2 -3, 2023

Venue: The 1st Auditorium, Taichung Veterans General Hospital, Taichung Taiwan

大會官網    節目概覽  台中烏日高鐵站至會場接駁車登記 烏日高鐵站大會接駁車停車處示意圖

(搭大會接駁車的人在台中高鐵站二樓4B出口(室內) 8:40  集合,會有人舉“2023 AAPPS”牌子)

(台中全國大飯店 - 台中榮總)接駁車時間表

~ 歡迎踴躍報名參加相關訊息 ~   國內早鳥報名繳費: 即日起至 11/20 截止   

          

【國內報名網站】:

1. 協辦學會會員及機構請在此網站報名: 2023AAPPS.NHRI.edu.tw/registration

2. 台灣病理學會會員及非會員皆可在此網站報名: https://www.twiap.org.tw/events/registration_other.php?id=1390

    * Gala Dinner 點我報名繳費   台中全國大飯店 , 12/2 (六)  18:30入場,19:00開始

    (報名後請於一周內繳費, 以完成報名手續. 若超過期限未繳費將釋出名額)

Registration Fee

Early bird (until Nov.20, 2023)

After Nov. 20, 2023 and Onsite Registration

病理學會會員

800

1000

病理住院醫師

600

800

海報投稿者**

400 

N/A

非病理學會會員

1000

1500

Gala Dinner

1000

  • 國內的海報投稿者請到大會網站報名 (https://2023aapps.nhri.edu.tw/),才能上傳摘要。報名費請到病理學會網站繳交,收費較低。
  • 亞澳肺臟病理學會將提供五個Poster awards ( USD 100) 和兩個 Travel award ( USD 500 )。歡迎踴躍報名。獲獎者也會被邀請參加Gala dinner,及頒獎典禮。

Day 1: 

December 2, 2023, The 1st Auditorium

Time

Topic

Speaker

Moderator

08:00-17:00

Registration

09:00-10:00

Session 1: Interesting cases of neoplastic and non-neoplastic lung diseases (case presentation)

09:00-09:15

Hepatoid Adenocarcinoma; Lung or Liver Primary?

Salmah Bakar

(Malaysia)

Wei-Chin Chang

張維鈞

Yuichi Ishikawa

09:15-09:30

Two Interesting Cases:

Atypical Sclerosing Pneumocytoma and Mesothelioma

Lisnawati Rachmadi

(Indonesia)

09:30-09:45

Pulmonary Pleomorphic Carcinoma - A Case Report

Hang Thi Nguyen (Vietnam)

Geon Kook Lee

Liang Che Chang
張良慈

09:45-10:00 Plasma Cell Neoplasm of Lung: Case Series

Noriah binti Othman

(Malaysia)

10:00-10:15

Opening Ceremony and Group Pictures

Yung-Ming Jeng, President, Taiwan Society of Pathology

Huey-Kang Sytwu, President, National Health Research Institutes

Osamu Matsubara, Distinguished Advisor, AAPPS

Hao-Chien Wang, President, Taiwan Society of Pulmonary and Critical Care Medicine

Pin-Kuei Fu, President, Taiwan Association of Promoting Care Continuity Chronic Disease
Shih-Ann Chen, Superintendent, Taichung Veterans General Hospital

Shiu-Feng Huang, Congress President

10:15-10:30

Coffee break

10:30-12:30

Session 2: Update in the Diagnosis and Therapy of Interstitial Lung Diseases (ILD)

10:30-10:50

Pathology update of acute lung injury

Osamu Matsubara

(Japan)

Pin-Kuei Fu
傅彬貴

Myoung Ja Chung

10:50-11:10

Acute / Chronic (fibrotic) hypersensitivity pneumonitis

Junya Fukuoka

(Japan)

11:10-11:30

Chronic Lung Injury: UIP and Common ILD Manifesting

 Progressive Pulmonary Fibrosis (PPF)

Myoung Ja Chung

         (Korea)

 Hao-Chien Wang

王鶴健

Osamu Matsubara

11:30-11:50

Pathologic approach to cryo-biopsy for interstitial

lung disease

Junya Fukuoka

(Japan)

11:50-12:10

Radiology perspective for Progressive Pulmonary Fibrosis

Yeun-Chung Chang

張允中

(Taiwan)

Meng-Chih Lin
林孟志

Junya Fukuoka

12:10-12:30

Pulmonary perspective for Progressive Pulmonary Fibrosis

Ping-Hung Kuo

郭炳宏

(Taiwan)

12:30-13:30

Lunch: Satellite symposium for ILD  (Boehringer Ingelheim)

Moderator: Meng-Chih Lin林孟志

Speakers: Hsin-Kuo Ko   Kuo-Tung Huang

13:30-15:25

Session 3: Update in the Diagnosis and Therapy in Infectious Lung Diseases

13:30-14:00

Viral Infections of Lung: A Pathologic-Virologic Correlation

Wun-Ju Shieh

(USA)

Kuo-Chin Kao
高國晉

Kum Thong Wong

14:00-14:25

Virological and Immunological Characterization of

COVID-19 Cases and Development of Animal Models

Tadaki Suzuki

(Japan)

14:25-14:45

A Comparison of COVID-19, SARS, and MERS

Wun-Ju Shieh

(USA)

Chieh-Liang Wu
吳杰亮

Tadaki Suzuki

14:45-15:05

Two autopsy cases presentation

Kum Thong Wong

(Malaysia)

15:05-15:25

Pathology in Covid: Singapore Experience in Two Epidemics

Angela Chong

(Singapore)

Wun-J Shieh

15:25-15:50

Coffee break (Poster Presentation)

15:50-17:05

Session 4: Pathology of Rare Lung Diseases

15:50-16:05

Primary melanocytic tumor of lung, case presentation

and review

Chih-Jung Chen

(Taiwan)

Kun Young Kwon
Nor Salmah Bakar

16:05-16:20

Histopathologic Intricacies in

The Diagnosis of Thoracic Inflammatory

Myofibroblastic Tumor

Treah May Suacillo-Sayo

(Philippine)

16:20-16:35

Thoracic SMARCA4-Deficient Undifferentiated Tumour

Lau Kah Weng

(Singapore)

Teh-Ying Chou

周德盈

Peter B. Illei

16:35-16:50

Cysts Can Be Deceiving: A series of

 cystic lung neoplasms in the pediatric population

Rouchelle D.dela Cruz

(Philippine)

16:50-17:05

A Rare Case of DPLD with Tracheal Myiasis in a 65 Year Male

Ritu Kulshrestha (India)

Angela Chong

Day 2: 

December 3, 2023, The 1st Auditorium

Time

Topic

Speaker

Moderator

08:00-16:00

Registration

08:30-10:20

Session 5: Update in the Pathology of Lung Cancers

08:30-08:50

Pathologic Diagnosis of Lung Cancer in Small Biopsy

Kunyoung Kwon

(Korea)

Jang Ming Lee

李章銘

Yi-Chen Yeh

葉奕成

08:50-09:10

Mucinous Adenocarcinoma of the Lung: a Progress and a Problem

Yuichi Ishikawa

(Japan)

09:10-09:30

Pathologic Evaluation of NSCLC after

Neoadjuvant Immuno-Chemotherapy

Geon Kook Lee

(Korea)

Tsung-Ying Yang

楊宗穎

Chang-Yao Chu

朱彰堯

09:30-09:50

Update in the AI Diagnosis for Lung Adenocarcinoma Invasion

Hitomi Kawai

(Japan)

09:50-10:20

Diagnosis of Lung Adenocarcinoma Invasion as Defined

by the IASLC Pathology Committee Working Group

Masayuki Noguchi

(Japan)

Chih-Yi Chen
陳志毅

10:20-10:50

Coffee break (Poster Presentation)

10:50-12:30

Session 6: Biomarker based Therapy and Pathology of Lung Cancers

10:50-11:10

Usefulness of BRAF VE1 IHC in NSCLC: a multi-institutional study

by 15 pathologists in Korea

Sunhee Chang

(Korea)

Shang-Jyh Kao
高尚志

Wen-Hui Ku
顧文輝

11:10-11:30

Detection of EGFR Exon 20 Insertion

Min-Shu Hsieh

(Taiwan)

11:30-11:50

Detection of MET Exon 14 Skipping Mutation in NSCLC

Hyo Sup Shim

(Korea)

Chao-Chi Ho
何肇基

Chien-Feng Li
李健逢

11:50-12:10

Multiple Lung Cancers: Application of Next Generation Sequencing in

the Distinction between Separate Primary Lung Cancers and

Intrapulmonary Metastases

Yi-Chen Yeh

(Taiwan)

12:10-12:30

Update in the Immunohistochemistry for Lung cancer Diagnosis

Takuo Hayashi

(Japan)

Min-Shu Hsieh

謝明書

12:30-13:30

Lunch Symposium: 

Real-World Experience of NGS-Directed Treatment in Lung Cancer  (Sofiva)

Moderator: Jin-Yuan Shih施金元

Speaker: Wei-Hsun Hsu徐偉勛

13:30-15:30

Session 7: Digital Pathology and AI for the Diagnosis and Treatment of Lung Diseases

13:30-13:55

AI to predict Lung Cancer Recurrence Risk and to Evaluate Therapy

Effect in Patients Receiving Targeted Therapy

Peter B. Illei

(USA)

Jin-Yuan Shih

施金元

Shumpei Ishikawa

13:55-14:15

Coexistence of Pathologists and AI

Shingo Sakashita

(Japan)

14:15-14:35

Quantifying Cancer Histopathology and its Application

Shumpei Ishikawa

(Japan)

Mong-Wei Lin

林孟暐

Masayuki Noguchi

14:35-14:55

AI for Lung Cancer Pathology Classification

Chi-Long Chen

(Taiwan)

14:55-15:15

AI–Powered Spatial Analysis of

 Tumor-Infiltrating Lymphocytes as Complementary

Biomarker for Immune Checkpoint Inhibition

 in Non–Small-Cell Lung Cancer

Yoon-La Choi

(Korea)

Yin-Kai Chao

趙盈凱

Jiun-Yi Hsia

夏君毅

15:15-15:30

Integrating Artificial Intelligence (AI) and Streamlined

Image Processing for Automated Detection of Mycobacterium 

Tuberculosis in Acid-Fast Stain Slides

Hsiang-Sheng Wang

(Taiwan)

15:30-15:45

Coffee break

15:45-17:20

Session 8: Mesothelioma: Diagnosis, Management and Challenges

15:45-16:00

Mesothelioma in Situ

Wei-Chin Chang

(Taiwan)

Kazuki Nabeshima

Cheng-Yen Chuang

莊政諺

16:00-16:20

An Update on the WHO classification of Mesothelioma

Sonja Klebe

(Australia)

16:20-16:40

Surrogate Immunostaining Assays for Mesothelioma Diagnosis

Kazuki Nabeshima

(Japan)

Chao-cheng Huang

黃昭誠

Sonja Klebe

16:40-17:00

Minimal Panel of Antibodies for the Cytological Diagnosis

of Mesothelioma

Kenzo Hiroshima

(Japan)

17:00-17:15

Mesotheliomas in Malaysia

Aniza Hassan

(Malaysia)

Kazuki Nabeshima

17:15-17:20

Closing remark

Shiu-Feng Huang

(Taiwan)

積分

1. 台灣病理學會 (16學分)、2. 台灣內科醫學會 (B類15學分) 、3. 台灣家庭醫學醫學會(10學分) 、4. 中華民國癌症醫學會 (腫瘤內科A類3學分、腫瘤外科A類3學分)

5. 台灣肺癌學會 (2學分)、6. 台灣胸腔暨重症加護醫學會(B類14學分) ,

7. 台灣腫瘤護理學會 (12/2: 6.5學分; 12/3: 7學分) 、8. 中華民國重症醫學會 (8學分)、9. 台灣胸腔及心臟血管外科學會 (30學分)

認定資料

認定字號 2023120203
認定積分 16
認定時數 16
積分類別 病理

聯絡資訊

聯絡人 余欣穎
聯絡電話 037-206166 ext. 35316
傳真 037-586459
電子信箱 2023aapps@gmail.com
網站連結

報名資訊

餐食 提供
費用
費用名稱 身份 開始時間 結束時間 費用
報名費_病理學會會員_ 2023 AAPPS (7th) 會員-主治醫師 2023/07/25 00:00 2023/11/23 00:00 800
報名費_病理學會會員_ 2023 AAPPS (7th) 會員-住院醫師 2023/07/25 00:00 2023/11/23 00:00 600
報名費_海報投稿者** 2023 AAPPS (7th) 會員 2023/07/25 00:00 2023/11/23 00:00 400
報名費_海報投稿者** 2023 AAPPS (7th) 非會員 2023/07/25 00:00 2023/11/23 00:00 400
報名費_非病理學會會員 2023 AAPPS (7th) 非會員 2023/07/25 00:00 2023/11/23 00:00 1,000
開立收據
人數限制
  • 90/180
  • 5/20
  • 95/200